These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2063711)

  • 1. Treatment of renal anemia, 1960-1990.
    Koch KM; Frei U
    Adv Nephrol Necker Hosp; 1991; 20():19-30. PubMed ID: 2063711
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin.
    Abels R
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):20-5. PubMed ID: 2192413
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPO--one year later. Fighting anemia in the courtroom.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 9. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 10. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 11. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin.
    Erslev AJ
    N Engl J Med; 1991 May; 324(19):1339-44. PubMed ID: 2017231
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin and chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Zingraff J; Delons S; Kreis H; Varet B
    Nouv Rev Fr Hematol (1978); 1989; 31(2):97-8. PubMed ID: 2771635
    [No Abstract]   [Full Text] [Related]  

  • 15. Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Peterlongo F; Castaigne JP; Zingraff J; Delons S
    Adv Nephrol Necker Hosp; 1989; 18():187-206. PubMed ID: 2493715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 19. EPO--one year later. Effects of EPO on nutritional status in CRF.
    Schiro KB
    Nephrol News Issues; 1990 May; 4(5):26, 34. PubMed ID: 2348876
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency].
    Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B
    Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.